Samsung C&T (028260 KS/Buy)Strong Results Backed by a Solid Business Portfolio
Strong results backed by a solid business portfolio2Q26 review: OP beats consensus by 18% Samsung C&T posted strong 2Q26 consolidated...
100 Views
Samsung C&T (028260 KS/Buy)Multiple Tailwinds from Samsung Electronics
Our semiconductor analyst’s target price for SEC stands at W550,000, implying approximately 56% upside from the current share price.
118 Views
Samsung C&T (028260 KS/Buy)Steady Rise in Both Operating and Asset Value
For 4Q25, Samsung C&T reported in-line results, with consolidated revenue of W10.8tr (+8.4% YoY) and operating profit of W822.3bn (+29.6% YoY; vs....
172 Views
Samsung C&T (028260 KS/Buy)Biologics Business Accounts for 73% of Operating Profit
For 3Q25, Samsung C&T reported consolidated revenue of W10.2tr (-1.5% YoY) and operating profit of W993.4bn (+35% YoY), with the latter beating the...
522 Views
Equity Strategy[February] Positioning for the Market’s Next Phase
Because the rally has been primarily earnings-driven, valuation pressure remains limited, with the KOSPI’s 12-month forward P/E standing at 10.6x.
201 Views